Is epistaxis associated with arterial hypertension? A systematic review of the literature

Abstract

Both epistaxis and hypertension are frequent problems in the adult population. The relationship between the level of arterial pressure and incidence of epistaxis in a patient with hypertension is a question that appears frequently in the clinical practice. A systematic review of the literature regarding the relation of arterial hypertension with epistaxis was performed through MEDLINE and EMBASE. All studies, whether examining the correlation of arterial pressure at presentation of a patient with nasal bleeding or the repercussion of episodes of epistaxis in hypertensive patients, were included in this review. Studies were evaluated independently by two reviewers according to a standard evaluation form. Overall, nine studies fulfilled our inclusion criteria. Five of them were single-group (patient) studies, while the remaining four included a control group. In eight studies, the patient group included patients with epistaxis, while one focused on hypertensive patients. Six out of nine studies agree that arterial pressure is higher at the time of epistaxis, as compared to the control group or to the general population. Seven out of nine studies conclude that there is cross-correlation between arterial pressure and the actual incident of epistaxis. The presence of high arterial blood pressure during the actual episode of nasal bleeding cannot establish a causative relationship with epistaxis, because of confounding stress and possible white coat phenomenon, but may lead to initial diagnosis of an already installed arterial hypertension.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Miniño AM (2009) Centers for disease control and prevention national center for health statistics death in the United States. NCHS Data Brief 64:1–8

    Google Scholar 

  2. 2.

    Yoon SS, Ostchega Y, Louis T (2010) Recent trends in the prevalence of high blood pressure and its treatment and control, 1999–2008. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; NCHS Data Brief no. 48 Monomi M., Death in the United States (2011) NCHS Data Brief. (64):1-8

  3. 3.

    Hall JE (2008) Hypertension: update. Hypertension 52(3):425–428

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Messerli FH, Williams B, Ritz E (2007) Essential hypertension. Lancet 18; 370(9587):591–603

    Article  Google Scholar 

  5. 5.

    Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P (1996) Hypertensive Urgencies and Emergencies, Prevalence and Clinical Presentation. Hypertension 27:144–147

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Rodriguez MA, Kumar SK, De Caro M (2010) Hypertensive Crisis. Cardiol Rev 18(2):102–107

    PubMed  Article  Google Scholar 

  7. 7.

    Kotecha B, Fowler S, Harkness P, Walmsley J, Brown P, Topham J (1996) Management of epistaxis: a national survey. Ann R Coll Surg Engl 78(5):444–446

    CAS  PubMed Central  PubMed  Google Scholar 

  8. 8.

    Goddard JC, Reiter ER (2005) Inpatient management of epistaxis: outcomes and cost. Otolaryngol Head Neck Surg 132(5):707–712

    PubMed  Article  Google Scholar 

  9. 9.

    Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 6(7):e1000097. doi:10.1371/journal.pmed.100009

    PubMed Central  PubMed  Article  Google Scholar 

  10. 10.

    Herkner H, Laggner AN, Müllner M, Formanek M, Bur A, Gamper G, Woisetschläger C, Hirschl MM (2000) Hypertension in patients presenting with epistaxis. Ann Emerg Med 35(2):126–130

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Dizdar O, Onal IK, Ozakin E, Karakiliç E, Karadag O, Kalyoncu U, Coşkun F, Buyukasik Y (2007) Research for bleeding tendency in patients presenting with significant epistaxis. Blood Coagul Fibrinolysis 18(1):41–43

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Fuchs FD, Moreira LB, Pires CP, Torres FS, Furtado MV, Moraes RS, Wiehe M, Fuchs SC, Lubianca Neto JF (2003) Absence of association between hypertension and epistaxis: a population-based study. Blood Press 12(3):145–148

    PubMed  Article  Google Scholar 

  13. 13.

    Herkner H, Havel C, Müllner M, Gamper G, Bur A, Temmel AF, Laggner AN, Hirschl MM (2002) Active epistaxis at ED presentation is associated with arterial hypertension. Am J Emerg Med 20(2):92–95

    PubMed  Article  Google Scholar 

  14. 14.

    Isezuo SA, Segun-Busari S, Ezunu E, Yakubu A, Iseh K, Legbo J, Alabi BS, Dunmade AE (2008) Relationship between epistaxis and hypertension: a study of patients seen in the emergency units of two tertiary health institutions in Nigeria. J Clin Pract 11(4):379–382

    CAS  Google Scholar 

  15. 15.

    Beran M, Petruson B (1986) Occurrence of epistaxis in habitual nose-bleeders and analysis of some etiological factors. ORL J Otorhinolaryngol Relat Spec 48(5):297–303

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Padgham N (1990) Epistaxis: anatomical and clinical correlates. J Laryngol Otolaryngol. 104(4):308–311

    CAS  Article  Google Scholar 

  17. 17.

    Lubianca Neto JF, Fuchs FD, Facco SR, Gus M, Fasolo L, Mafessoni R, Gleissner AL (1999) Is epistaxis evidence of end-organ damage in patients with hypertension? Laryngoscope 109(7 Pt 1):1111–1115

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Charles R, Corrigan E (1977) Epistaxis and hypertension. Postgrad Med J 53(619):260–261

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Rudmik L, Smith TL (2012) Management of intractable spontaneous epistaxis. Am J Rhinol Allergy 26(1):55–60

    PubMed  Article  Google Scholar 

  20. 20.

    Agreda B, Urpegui A, Ignacio Alfonso J (2011) Ligation of the sphenopalatine artery in posterior epistaxis: retrospective study of 50 patients Valles H. Acta Otorrinolaringol Esp 62(3):194–198

    PubMed  Article  Google Scholar 

  21. 21.

    Turgay C, Atila I, Uygar C, Serdar K, Yalcin T, Ersoy I (2010) A new evidence of end-organ damage in patients with arterial hypertension: epistaxis? Int J Cardiol 141(1):105–107

    Article  Google Scholar 

  22. 22.

    Rizzoni D, Muiesan ML, Porteri E, De Ciuceis C, Boari GE, Salvetti M, Paini A, Rosei EA (2009) Vascular remodeling, macro- and microvessels: therapeutic implications. Blood Press 18(5):242–246

    PubMed  Google Scholar 

  23. 23.

    Rafflenbeul W (1994) Hypertension treatment and prevention of new atherosclerotic plaque formation. Drugs 48(Suppl 1):11–15

    PubMed  Article  Google Scholar 

  24. 24.

    Kitamoto S, Egashira K (2004) Endothelial dysfunction and coronary atherosclerosis. Curr Drug Targets Cardiovasc Haematol Disord 4(1):13–22

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Miller AA, Drummond GR, Kemp-Harper BK, Sobey CG (2011) Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci 1(16):1733–1745

    Google Scholar 

  26. 26.

    Rymer MM (2011) Hemorrhagic stroke: intracerebral hemorrhage. Mo Med 108(1):50–54

    PubMed  Google Scholar 

  27. 27.

    Inagawa T (2010) Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane Japan. World Neurosurg 73(3):155–164

    PubMed  Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. Hantzakos.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kikidis, D., Tsioufis, K., Papanikolaou, V. et al. Is epistaxis associated with arterial hypertension? A systematic review of the literature. Eur Arch Otorhinolaryngol 271, 237–243 (2014). https://doi.org/10.1007/s00405-013-2450-z

Download citation

Keywords

  • Epistaxis
  • Hypertension
  • Blood pressure